The effect was seen across a wide variety of addictive and habit-forming substances, including cocaine, opioids, alcohol, ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

GLP-1 drugs, like semaglutide, may help people avoid developing addictions to alcohol, tobacco, and drugs such as cannabis ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

By Nancy Lapid March 4 (Reuters) - Ozempic, Mounjaro and other GLP-1 drugs for diabetes can prevent new substance use ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

Study of 600,000 US military veterans shows that those who took anti-obesity medications were less likely to develop some complications of substance-use disorders.

The American College of Obstetricians and Gynecologists and American Academy of Pediatrics say the science does not clearly ...

With GLP-1 drugs becoming more accessible and affordable, they could also be within reach for substance use treatment.

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows. Semaglutide (also known as Ozempic) ...